Teva Pharmaceutical Industries Limited (TEVA)
After hours:
| Previous Close | 8.64 |
| Open | 8.60 |
| Bid | 8.47 x 2900 |
| Ask | 8.50 x 2200 |
| Day's Range | 8.45 - 8.72 |
| 52 Week Range | 7.73 - 13.30 |
| Volume | |
| Avg. Volume | 10,511,682 |
| Market Cap | 9.85B |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | 12.89 |
| EPS (TTM) | 0.66 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov. 27, 2017 |
| 1y Target Est | 11.36 |
- Motley Fool
3 Turnaround Stocks That Can Bounce Back Big Time in 2022
If we strictly looked at the performance of the major U.S. stock indexes, 2021 was a great year. While no investor enjoys seeing their stocks go in reverse, patience has a way of paying off handsomely in the stock market. In 2022, the following trio of turnaround stocks have the catalysts needed to bounce back in a big way.
- Reuters
Teva settles shareholder lawsuit over generic drug pricing for $420 million
(Reuters) -Teva Pharmaceutical Industries Ltd has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive scheme to fix the price of generic drugs. Teva spokesperson Kelley Dougherty said the "vast majority" of the settlement will be funded by the company's insurers. "This resolution is in the overall best interest of Teva and the patients who continue to rely on us each day for the world’s largest portfolio of generics medicines," Dougherty said in an email.
- Reuters
UPDATE 2-Teva settles shareholder lawsuit over generic drug pricing for $420 mln
Teva Pharmaceutical Industries Ltd has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive scheme to fix the price of generic drugs. Teva spokesperson Kelley Dougherty said the "vast majority" of the settlement will be funded by the company's insurers. "This resolution is in the overall best interest of Teva and the patients who continue to rely on us each day for the world’s largest portfolio of generics medicines," Dougherty said in an email.
